Top Industry News
- MHRA Shares Guidance on Labeling and Packaging Under New Brexit Rules
- ANVISA Regulatory Framework for Drug Labeling is Improved
- EMA Updates Q&A Document on Publication of Clinical Trial Data
- Taiwan FDA Drafts Restrictions on the Use and Labeling of Eight Ingredient to be used as Food Material
- MHRA Medical Devices: Guidance for Manufacturers on Vigilance
- The time for Renewing Your AICIS Registration is Approaching
- Global Regulatory Review of the Food Additive Titanium Dioxide by the National Health Surveillance Agency (ANVISA)
- MHRA CE Marking Recognition for Medical devices and in vitro diagnostics
- FDA Assessing User Fees Under the Biosimilar User Fee Amendments of 2022
- EFSA- Evaluation by Peers of the Risk Assessment for the Pesticide's Active Ingredient, Milbemectin
- Follow‐up of the Re‐evaluation of Indigo Carmine (E 132) as a Food Additive by EFSA